These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10027555)

  • 1. Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.
    Toji H; Maruyama H; Sasaki K; Nakamura S; Kawakami H
    Neurosci Lett; 1999 Jan; 259(1):56-8. PubMed ID: 10027555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No evidence of association between apolipoprotein E gene regulatory region polymorphism and Alzheimer's disease in Japanese.
    Kimura M; Matsushita S; Arai H; Matsui T; Yuzuriha T; Higuchi S
    J Neural Transm (Vienna); 2000; 107(12):1449-56. PubMed ID: 11458997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].
    Shimada K; Yasuda M; Maeda K
    Seishin Shinkeigaku Zasshi; 1997; 99(8):575-87. PubMed ID: 9369084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.
    Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Luna JL
    Neurosci Lett; 2001 May; 304(3):204-8. PubMed ID: 11343837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
    Wang JC; Kwon JM; Shah P; Morris JC; Goate A
    Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the relation between the apolipoprotein E promoter -427C/T polymorphism and Alzheimer's disease].
    Tang GM; Zhang MY; Jiang SD; Qian YP; Wang DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):244-6. PubMed ID: 12778455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.
    Nacmias B; Tedde A; Latorraca S; Piacentini S; Bracco L; Amaducci L; Guarnieri BM; Petruzzi C; Ortenzi L; Sorbi S
    Ann Neurol; 1996 Oct; 40(4):678-80. PubMed ID: 8871590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
    Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease.
    Casadei VM; Ferri C; Veglia F; Gavazzi A; Salani G; Cattaneo M; Sorbi S; Annoni G; Licastro F; Mariani C; Franceschi M; Grimaldi LM
    Neurology; 1999 Nov; 53(8):1888-9. PubMed ID: 10563653
    [No Abstract]   [Full Text] [Related]  

  • 10. No synergistic effect between -850 tumor necrosis factor-alpha promoter polymorphism and apolipoprotein E epsilon 4 allele in Alzheimer's disease.
    Infante J; Llorca J; Berciano J; Combarros O
    Neurosci Lett; 2002 Aug; 328(1):71-3. PubMed ID: 12123862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
    Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
    J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans.
    Kim KW; Jhoo JH; Lee KU; Lee DY; Lee JH; Youn JY; Lee BJ; Han SH; Woo JI
    Neurosci Lett; 1999 Dec; 277(3):145-8. PubMed ID: 10626834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
    Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
    Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.
    Halimi G; Duplan L; Bideau C; Iniesta D; Berthézène P; Oddoze C; Verdier JM; Michel B; Bergé-Lefranc JL
    Neuroreport; 2000 Nov; 11(16):3599-601. PubMed ID: 11095526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.
    Yang JD; Feng GY; Zhang J; Cheung J; St Clair D; He L; Ichimura K
    Neurosci Lett; 2003 Oct; 350(1):25-8. PubMed ID: 12962909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease.
    Chen L; Baum L; Ng HK; Chan LY; Sastre I; Artíga MJ; Valdivieso F; Bullido MJ; Chiu HF; Pang CP
    Neurosci Lett; 1999 Jul; 269(3):173-7. PubMed ID: 10454160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.
    Juhász A; Palotás A; Janka Z; Rimanóczy A; Palotás M; Bódi N; Boda K; Zana M; Vincze G; Kálmán J
    Neurochem Res; 2005 May; 30(5):591-6. PubMed ID: 16176061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern.
    Scacchi R; Gambina G; Martini MC; Ruggeri M; Ferrari G; Silvestri M; Schiavon R; Corbo RM
    Dement Geriatr Cogn Disord; 2001; 12(2):63-8. PubMed ID: 11173876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.
    Town T; Paris D; Fallin D; Duara R; Barker W; Gold M; Crawford F; Mullan M
    Neurosci Lett; 1998 Aug; 252(2):95-8. PubMed ID: 9756330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.